Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) insider Jeffrey C. Kunins sold 1,370 shares of Axon Enterprise stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $639.14, for a total value of $875,621.80. Following the completion of the sale, the insider now directly owns 125,950 shares of the company’s stock, valued at $80,499,683. The trade was a 1.08 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Axon Enterprise Price Performance
NASDAQ:AXON opened at $615.68 on Friday. The business’s 50-day simple moving average is $555.56 and its two-hundred day simple moving average is $414.18. Axon Enterprise, Inc. has a 52 week low of $241.72 and a 52 week high of $698.67. The stock has a market cap of $46.95 billion, a PE ratio of 159.09, a P/E/G ratio of 14.19 and a beta of 1.01. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on AXON. JMP Securities raised their target price on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities lifted their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $488.67.
Institutional Trading of Axon Enterprise
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Quent Capital LLC grew its holdings in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares in the last quarter. Prestige Wealth Management Group LLC lifted its holdings in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares in the last quarter. Blue Trust Inc. boosted its position in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Brooklyn Investment Group purchased a new position in Axon Enterprise during the third quarter valued at $41,000. Finally, Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 55 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- The Significance of Brokerage Rankings in Stock Selection
- Micron Stock Under $100: Seize the AI-Driven Upside
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- 3 Warren Buffett Stocks to Buy Now
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.